Modeling of the in vivo kinetics of antioxidants delineates suitable parameters for selecting potential antioxidant adjuvants for cancer therapy

Pharmaceutical Biology
Ming-Hua YangRobert Y Peng

Abstract

To find in vivo behaviors of an antioxidant when used as an adjuvant cancer therapy, a more detailed integrated pharmacokinetic scheme is needed. Major reaction parameters associated with the sequential routes from ingestion to decay of an antioxidant were used in mathematical analysis, which included absorption rate coefficient k(a), quenching rate coefficient of the antioxidant k(q1) and tissue quenching rate coefficient k(r). The model was then treated with computer simulation using cited decay rate coefficients and some assumed parameters. When intestinal absorption rate coefficient k(a) becomes larger, retention time of antioxidant in plasma would be prolonged. moreover, k(a) had no effect on either quenching ability of antioxidants or tissue recovering capability. in quenching plasma ROS, the larger the quenching coefficient k(q1), the shorter peak- and the life-times would be for the secondary free radicals that are formed in primary quenching. Conclusively, it is suggestive to prescribe an antioxidant therapy with an appropriate values of k(a) and larger values of k(q1).

References

Nov 1, 1989·Archives of Biochemistry and Biophysics·P Di MascioH Sies
May 1, 1987·The American Journal of Clinical Nutrition·K F GeyH B Stähelin
Dec 1, 1995·The American Journal of Clinical Nutrition·H Sies, W Stahl
Jan 1, 1995·Critical Reviews in Food Science and Nutrition·B HalliwellO I Aruoma
Oct 1, 1996·Journal of the American Dietetic Association·K A Steinmetz, J D Potter
Apr 29, 1998·Nature·I D PodmoreJ Lunec
May 26, 1998·Biochemical and Biophysical Research Communications·A RehmanC Rice-Evans
Oct 29, 1999·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·P C Hollman, M B Katan
May 22, 2001·Archives of Biochemistry and Biophysics·A J Young, G M Lowe
Nov 14, 2002·Biochemical Pharmacology·Domenico LapennaFranco Cuccurullo
Nov 26, 2002·Free Radical Biology & Medicine·Gareth W DavisonTony Ashton
Dec 11, 2002·Biochemical Pharmacology·Natalia UdilovaHans Nohl
Jan 16, 2003·Journal of the American Chemical Society·Sara GoldsteinAmram Samuni
Mar 22, 2003·Gynecologic Oncology·Jeanne A DriskoVerda J Hunter
May 15, 2003·Journal of Agricultural and Food Chemistry·Bolívar A Cevallos-Casals, Luis Cisneros-Zevallos
May 15, 2003·Journal of Agricultural and Food Chemistry·Joo Yeon KimMun Yhung Jung
Sep 19, 2003·Biochemical and Biophysical Research Communications·Stephen S LeonardXianglin Shi
Dec 5, 2003·Photochemistry and Photobiology·Z MatuszakP Bilski
Dec 19, 2003·Free Radical Biology & Medicine·Dirk TaubertRenate Roesen
Jul 15, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N I WeijlS Osanto
Sep 30, 2004·Environmental Management·Steven R PotterJimmy R Williams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.